These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 123966)

  • 1. Proteases during the growth of Ehrlich ascites tumor. I. The fibrinolysin system.
    LeBlanc PP; Back N
    J Natl Cancer Inst; 1975 Apr; 54(4):881-6. PubMed ID: 123966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concentration of fibronectin in plasma of tumor-bearing mice and synthesis by Ehrlich ascites tumor cells.
    Zardi L; Cecconi C; Barbieri O; Carnemolla B; Picca M; Santi L
    Cancer Res; 1979 Sep; 39(9):3774-9. PubMed ID: 383288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteases during the growth of Ehrlich ascites tumor. II. The kallikrein-kinin system.
    LeBlanc PP; Back N
    J Natl Cancer Inst; 1975 May; 54(5):1107-4. PubMed ID: 236396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of ascitic fluid on the growth of Ehrlich tumor and Lewis carcinoma].
    Donenko FV; Kabieva AO; Moroz LV
    Biull Eksp Biol Med; 1992 Jul; 114(8):191-3. PubMed ID: 1467491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of interferon and other lymphokines during murine tumour growth. II. Induction of an interferon by Ehrlich ascites cells in outbred mice.
    Lackovic V; Borecký L; Zschiesche W; Fahlbusch B; Schumann I
    Acta Virol; 1980 Jan; 24(1):45-54. PubMed ID: 6155777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The modelling of the growth of Ehrlich carcinoma and teratoma T-36 with ascitic fluid and tumor-cell dialysate].
    Donenko FV; Kabieva AO; Moroz LV
    Biull Eksp Biol Med; 1992 Jul; 114(8):193-5. PubMed ID: 1467492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Polymorphism of a tumor cell population and selective processes. II. Change in the correlation of the numbers of 2 subpopulations of Ehrlich-Ich Ph ascites tumor cells in mice under the action of cell-free ascitic fluid and its fractions].
    Fomina MM; Minenkova EA; Evseenko LS; Poroshenko GG
    Tsitologiia; 1978 Dec; 20(12):1401-6. PubMed ID: 734778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Blood ammonia in mice bearing Ehrlich ascites tumors].
    Carrascosa JM; Martínez P; Núñez de Castro I
    Rev Esp Fisiol; 1982; 38 Suppl():195-8. PubMed ID: 7146577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble aminopeptidase N/CD13 in malignant and nonmalignant effusions and intratumoral fluid.
    van Hensbergen Y; Broxterman HJ; Hanemaaijer R; Jorna AS; van Lent NA; Verheul HM; Pinedo HM; Hoekman K
    Clin Cancer Res; 2002 Dec; 8(12):3747-54. PubMed ID: 12473585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A factor responsible for increases in ornithine decarboxylase activity in the livers of tumor-bearing mice.
    Noguchi T; Kashiwagi A; Tanaka T
    Cancer Res; 1976 Nov; 36(11 Pt 1):4015-22. PubMed ID: 975047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteases in human tumors.
    Burtin P; Chavanel G; Fondaneche MC
    Bull Cancer; 1984; 71(5):474-80. PubMed ID: 6240998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purine nucleotide levels in host tissues of Ehrlich ascites tumor-bearing mice in different growth phases of the tumor.
    Siems WG; Grune T; Schmidt H; Tikhonov YV; Pimenov AM
    Cancer Res; 1993 Nov; 53(21):5143-7. PubMed ID: 8221650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective processing of the transforming growth factor-beta1 in azoxymethane-induced mouse colon tumors.
    Guda K; Claffey KP; Dong M; Nambiar PR; Rosenberg DW
    Mol Carcinog; 2003 May; 37(1):51-9. PubMed ID: 12720300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [3H-thymidine incorporation into the DNA of the nucleic factor in the ascitic fluid of Ehrlich cancer].
    Belokhvostov AS
    Eksp Onkol; 1985; 7(6):50-3. PubMed ID: 4085399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Action of brinase on human fibrinogen and plasminogen.
    Vanhove P; Donati MB; Claeys H; Verhaeghe R; Vermylen J
    Thromb Haemost; 1979 Aug; 42(2):571-81. PubMed ID: 159511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic activity of the Ehrlich ascites carcinoma cells and the significance of ascites serum addition.
    Miko M; Drobnica L
    Neoplasma; 1969; 16(2):161-9. PubMed ID: 5822918
    [No Abstract]   [Full Text] [Related]  

  • 17. Natural cell-mediated cytotoxicity in Ehrlich ascites tumor-bearing mice.
    Olinescu A; Hristescu S; Mazilu E
    Neoplasma; 1983; 30(2):147-52. PubMed ID: 6843720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The kinetics of changes in sulfhydryl and disulfide groups and proteins during growth of Ehrlich ascites tumor].
    Romanovskii IV; Agatova AI; Novikova EN
    Vopr Onkol; 1973; 19(6):60-4. PubMed ID: 4778562
    [No Abstract]   [Full Text] [Related]  

  • 19. Post-traumatic plasminogenesis in intraarticular exudate in the knee joint.
    Rość D; Powierza W; Zastawna E; Drewniak W; Michalski A; Kotschy M
    Med Sci Monit; 2002 May; 8(5):CR371-8. PubMed ID: 12011780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vampire bat salivary plasminogen activator promotes robust lysis of plasma clots in a plasma milieu without causing fluid phase plasminogen activation.
    Hare TR; Gardell SJ
    Thromb Haemost; 1992 Aug; 68(2):165-9. PubMed ID: 1412162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.